Relmada Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications.
CEOSergio Traversa
CEOSergio Traversa
Employees20
Employees20
HeadquartersCoral Gables, Florida
HeadquartersCoral Gables, Florida
Founded2012
Founded2012
Employees20
Employees20
RLMD Key Statistics
Market cap111.64M
Market cap111.64M
Price-Earnings ratio-1.12
Price-Earnings ratio-1.12
Dividend yield—
Dividend yield—
Average volume129.46K
Average volume129.46K
High today$3.83
High today$3.83
Low today$3.62
Low today$3.62
Open price$3.62
Open price$3.62
Volume64.01K
Volume64.01K
52 Week high$7.22
52 Week high$7.22
52 Week low$2.36
52 Week low$2.36